Half-life,tissue distribution and excretion of human tissue urokinase type plasminogen activator after single-dose intravenous injection in rats
Shen Long-hai
Abstract
Shen Long-hai
Abstract
Objective To evaluate the half-life,tissues distribution and excretion of human tissue urokinase type plasminogen activator(HTUPA) in SD rats.Methods Using 125I labeled HTUPA as a tracer,the samples of plasma,tissue,bile,urine and fecal were collected from the test rats at the various time points with various dosage after single-dose intravenous injection and measured by counting TCA-precipitable radioactivity.Half-life,tissue distribution and excretion rate were evaluated.Results The concentration-time curve of HTUPA was fitted to a two-compartment model after intravenous injection with the dosages of 1,2 and 4 mg/kg,respectively;with the mean distribution half life(t1/2a) of(5.62±4.22),(6.37±4.93) and(6.57±4.13) min,respectively;Also,blood clearance showed elimination half life(t1/2b) of(49.21±19.36),(41.17±18.50) and(43.68±28.67) min,respectively.A linear relationship was found between the dose and area under the curve(AUCinf) with r=0.998 5.After the rats being injected with HTUPA of 2 mg/kg,the concentration of the HTUPA was higher in kidney and liver,and was lower in brain.Additionally,the excretion ratios of the HTUPA into urine and feces at 96 h were 79.08% and 15.40%,respectively,and it was 6.67% in bile at 24 h.Conclusion As a new candidate of thrombolytic drug,HTUPA has faster distribution speed and appropriate half life.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the half-life,tissues distribution and excretion of human tissue urokinase type plasminogen activator(HTUPA) in SD rats.Methods Using 125I labeled HTUPA as a tracer,the samples of plasma,tissue,bile,urine and fecal were collected from the test rats at the various time points with various dosage after single-dose intravenous injection and measured by counting TCA-precipitable radioactivity.Half-life,tissue distribution and excretion rate were evaluated.Results The concentration-time curve of HTUPA was fitted to a two-compartment model after intravenous injection with the dosages of 1,2 and 4 mg/kg,respectively;with the mean distribution half life(t1/2a) of(5.62±4.22),(6.37±4.93) and(6.57±4.13) min,respectively;Also,blood clearance showed elimination half life(t1/2b) of(49.21±19.36),(41.17±18.50) and(43.68±28.67) min,respectively.A linear relationship was found between the dose and area under the curve(AUCinf) with r=0.998 5.After the rats being injected with HTUPA of 2 mg/kg,the concentration of the HTUPA was higher in kidney and liver,and was lower in brain.Additionally,the excretion ratios of the HTUPA into urine and feces at 96 h were 79.08% and 15.40%,respectively,and it was 6.67% in bile at 24 h.Conclusion As a new candidate of thrombolytic drug,HTUPA has faster distribution speed and appropriate half life.
Key concepts: Urine, Excretion, Urokinase, Distribution (mathematics), Medicine, Half-life, Plasminogen activator, Pharmacokinetics